Drug Side Effects
Search
ONCOGENIC OSTEOMALACIA
ONCOGENIC OSTEOMALACIA
was reported 7 times
ONCOGENIC OSTEOMALACIA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
4
0.0001
1
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
4
0.0000
2
Platinum-based Drug [EPC]
1
0.0000